Tags

Tags

Displaying 41 - 50 of 68
Cover image of When scientific curiosity sparks innovation

When scientific curiosity sparks innovation

05 Dec 2018
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official side event to the world-renowned Slush. Techy events like these may seem almost science fictional at moments and it can be…
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official side event to the world-renowned Slush. Techy events like…
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official side event to the world…
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official side event to the world-renowned Slush. Techy…
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official…
Cover image of Medical imaging: Can we predict how cancer patients will respond to nanotherapies?

Medical imaging: Can we predict how cancer patients will respond to nanotherapies?

01 Oct 2018
Despite holding out promise for cancer treatments, nanomedicine lacks the means to predict patient response to tumour-targeting therapy. Prof. Twan Lammers has devised imaging which differentiates between those likely to benefit and those unlikely…
Despite holding out promise for cancer treatments, nanomedicine lacks the means to predict patient response to tumour-targeting therapy. Prof. Twan Lammers has devised imaging which…
Despite holding out promise for cancer treatments, nanomedicine lacks the means to predict patient response to tumour-targeting therapy. Prof. Twan…
Despite holding out promise for cancer treatments, nanomedicine lacks the means to predict patient response to tumour-targeting therapy. Prof. Twan Lammers has devised…
Despite holding out promise for cancer treatments, nanomedicine lacks the means to predict patient response to tumour…
Cover image of Organoids in the fight against cancer

Organoids in the fight against cancer

29 Jun 2018
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that replicate genetic events in CRC, as tools to test novel therapeutics.
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that replicate…
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional…
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that…
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex…

Understanding acidification to fight infection

28 May 2018
Prof. Giulio Superti-Furga and his team work on understanding the movement of molecules across human cells. In a paper recently published on Cell Host & Microbe, they outline the significance of a single protein, SLC4A7, in phagocytosis, the…
Prof. Giulio Superti-Furga and his team work on understanding the movement of molecules across human cells. In a paper recently published on Cell Host & Microbe, they outline the…
Prof. Giulio Superti-Furga and his team work on understanding the movement of molecules across human cells. In a paper recently published on Cell…
Prof. Giulio Superti-Furga and his team work on understanding the movement of molecules across human cells. In a paper recently published on Cell Host & Microbe, they…
Prof. Giulio Superti-Furga and his team work on understanding the movement of molecules across human cells. In a paper…
Cover image of Building a multi-level simulation of organogenesis

Building a multi-level simulation of organogenesis

20 Jul 2017
Organogenesis is the process by which different cells grow, differentiate and interact with each other to create large structures, such as the heart, the brain, a limb. But what are the mechanisms behind these molecular, cellular and tissue…
Organogenesis is the process by which different cells grow, differentiate and interact with each other to create large structures, such as the heart, the brain, a limb. But what are…
Organogenesis is the process by which different cells grow, differentiate and interact with each other to create large structures, such as the heart,…
Organogenesis is the process by which different cells grow, differentiate and interact with each other to create large structures, such as the heart, the brain, a limb. But…
Organogenesis is the process by which different cells grow, differentiate and interact with each other to create large…
Cover image of Leukaemia: an epigenetic disease?

Leukaemia: an epigenetic disease?

20 Jul 2017
All cancers carry epigenetic alterations. But the biological function of these alterations is not well understood. In his ERC project, Prof. Christoph Bock explores their functional role by introducing these alterations into cancer and normal cells…
All cancers carry epigenetic alterations. But the biological function of these alterations is not well understood. In his ERC project, Prof. Christoph Bock explores their functional…
All cancers carry epigenetic alterations. But the biological function of these alterations is not well understood. In his ERC project, Prof…
All cancers carry epigenetic alterations. But the biological function of these alterations is not well understood. In his ERC project, Prof. Christoph Bock explores their…
All cancers carry epigenetic alterations. But the biological function of these alterations is not well understood. In his…
Cover image of Frontier science and business that makes a difference

Frontier science and business that makes a difference

01 Apr 2017
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up,…
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded…
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and…
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira,…
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee),…
Cover image of Riding a Trojan horse against cancer

Riding a Trojan horse against cancer

24 Mar 2017
Magdalena Król is Professor at the Faculty of Veterinary Medicine of the Warsaw University of Life Sciences (SGGW) in Poland. She specializes in cancer research. Since 2006 Professor Król and her team have been investigating canine mammary cancer…
Magdalena Król is Professor at the Faculty of Veterinary Medicine of the Warsaw University of Life Sciences (SGGW) in Poland. She specializes in cancer research. Since 2006 Professor…
Magdalena Król is Professor at the Faculty of Veterinary Medicine of the Warsaw University of Life Sciences (SGGW) in Poland. She specializes in…
Magdalena Król is Professor at the Faculty of Veterinary Medicine of the Warsaw University of Life Sciences (SGGW) in Poland. She specializes in cancer research. Since 2006…
Magdalena Król is Professor at the Faculty of Veterinary Medicine of the Warsaw University of Life Sciences (SGGW) in Poland…
Cover image of Novel therapy starves the engine driving cancer cell growth

Novel therapy starves the engine driving cancer cell growth

05 Dec 2016
European researchers have identified a novel approach to prevent the growth of cancer tumours and inhibit them from spreading, potentially leading to highly effective treatments with fewer side effects.
European researchers have identified a novel approach to prevent the growth of cancer tumours and inhibit them from spreading, potentially leading to highly effective treatments with…
European researchers have identified a novel approach to prevent the growth of cancer tumours and inhibit them from spreading, potentially leading to…
European researchers have identified a novel approach to prevent the growth of cancer tumours and inhibit them from spreading, potentially leading to highly effective…
European researchers have identified a novel approach to prevent the growth of cancer tumours and inhibit them from…